A detailed history of Bank Of America Corp transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 854,195 shares of FATE stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
854,195
Previous 1,985,732 56.98%
Holding current value
$1.96 Million
Previous $6.51 Million 54.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.12 - $5.57 $3.53 Million - $6.3 Million
-1,131,537 Reduced 56.98%
854,195 $2.99 Million
Q2 2024

Aug 14, 2024

BUY
$3.26 - $7.08 $215,016 - $466,968
65,956 Added 3.44%
1,985,732 $6.51 Million
Q1 2024

May 15, 2024

BUY
$3.54 - $8.35 $4.65 Million - $11 Million
1,312,772 Added 216.27%
1,919,776 $14.1 Million
Q4 2023

Feb 14, 2024

SELL
$1.65 - $3.94 $1.01 Million - $2.42 Million
-614,904 Reduced 50.32%
607,004 $2.27 Million
Q2 2023

Aug 14, 2023

SELL
$4.76 - $6.59 $4.44 Million - $6.15 Million
-932,621 Reduced 43.29%
1,221,908 $5.82 Million
Q1 2023

May 12, 2023

BUY
$4.24 - $11.12 $7.11 Million - $18.6 Million
1,676,652 Added 350.85%
2,154,529 $12.3 Million
Q4 2022

Feb 10, 2023

BUY
$9.86 - $23.83 $1.41 Million - $3.41 Million
142,932 Added 42.67%
477,877 $4.82 Million
Q3 2022

Nov 14, 2022

BUY
$21.04 - $36.06 $349,390 - $598,812
16,606 Added 5.22%
334,945 $7.51 Million
Q2 2022

Aug 12, 2022

SELL
$17.78 - $42.39 $102,626 - $244,675
-5,772 Reduced 1.78%
318,339 $7.89 Million
Q1 2022

May 16, 2022

SELL
$29.67 - $60.28 $1.75 Million - $3.56 Million
-59,086 Reduced 15.42%
324,111 $12.6 Million
Q4 2021

Feb 08, 2022

BUY
$47.84 - $64.34 $6.79 Million - $9.14 Million
142,026 Added 58.89%
383,197 $22.4 Million
Q3 2021

Nov 15, 2021

SELL
$59.27 - $95.73 $1.42 Million - $2.29 Million
-23,921 Reduced 9.02%
241,171 $14.3 Million
Q2 2021

Sep 13, 2021

BUY
$67.25 - $92.52 $17.8 Million - $24.5 Million
265,092 New
265,092 $23 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.